Navigation Links
Sono-Tek Announces Second Quarter Results
Date:10/12/2009

MILTON, N.Y., Oct. 12 /PRNewswire-FirstCall/ -- Sono-Tek Corporation (OTC Bulletin Board: SOTK) today announced sales of $1,683,883 for the three months ended August 31, 2009, compared to sales of $1,605,482 for the prior year period, an increase of $78,401 or 5%. Sales also increased versus our first quarter by $219,155 or 15% in coating equipment for alternative energy, medical device equipment, food processing equipment and other industrial coating equipment. The latter two areas are also "green" in that we are displacing wasteful conventional spraying systems with our ultrasonic atomization technology. The Company reported net income of $40,546 for the three months ended August 31, 2009 compared to a loss of ($177,296) for the three months ended August 31, 2008. The current period profit resulted from higher sales volume combined with previous cost reductions and a reduced break-even point.

Dr. Christopher L. Coccio, Sono-Tek's Chairman and CEO, commented that "We announced in recent communications a goal of bringing the business back to a profitable mode again, and we are now achieving it. We spent money last year to build new technology, market, and business segments, and these efforts are now paying off for us. Senior management also took voluntary pay reductions at the beginning of this fiscal year to demonstrate our commitment to the future, and these are still in place. As we look at the next quarter, we expect both another double digit increase in our sales, as well as stronger profits."

For further information, contact Dr. Christopher L. Coccio, at 845-795-2020, or visit our website at www.sono-tek.com

Sono-Tek Corporation is a leading developer and manufacturer of liquid spray products based on its proprietary ultrasonic nozzle technology. Founded in 1975, the Company's products have long been recognized for their performance, quality, and reliability.

This earnings release contains forward looking statements regarding future events and the future performance of Sono-Tek Corporation that involve risks and uncertainties that could cause actual results to differ materially. These factors include, among other considerations, general economic and business conditions; political, regulatory, competitive and technological developments affecting the Company's operations or the demand for its products; timely development and market acceptance of new products; adequacy of financing; capacity additions, the ability to enforce patents and the ability to achieve increased sales volume and continued profitability. We refer you to documents that the company files with the Securities and Exchange Commission, which includes Form 10-K and Form 10-Qs containing additional important information.


                                 Sono-Tek Corporation
                               Selected Financial Data
                                      Unaudited

                                Six Months Ended         Three Months Ended
                                    August 31,               August  31,
                                2009          2008        2009         2008
                                ----          ----        ----         ----

     Net Sales            $3,148,612    $3,226,003  $1,683,883   $1,605,482
                          ==========    ==========  ==========   ==========

     Net (Loss) Income     ($128,881)    ($307,754)    $40,546    ($177,296)
                          ==========    ==========     =======   ==========

     Basic Earnings Per
      Share                   ($0.01)       ($0.02)      $0.00       ($0.01)
                          ==========    ==========  ==========   ==========

     Diluted Earnings Per
      Share                   ($0.01)       ($0.02)      $0.00       ($0.01)
                          ==========    ==========  ==========   ==========

     Weighted Average
      Shares - Basic      14,414,728    14,364,732  14,414,741   14,368,374
                          ==========    ==========  ==========   ==========

     Weighted Average
      Shares - Diluted    14,414,728    14,364,732  14,476,241   14,368,374
                          ==========    ==========  ==========   ==========

SOURCE Sono-Tek Corporation


'/>"/>
SOURCE Sono-Tek Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Election of Ian Clark and Pedro Granadillo to Board of Directors
2. Stereotaxis Announces Underwriters Exercise of Over-Allotment Option
3. CSL Behring Announces FDA Approval of Berinert(R), First and Only Therapy Approved for the Treatment of Acute Abdominal and Facial Attacks of Hereditary Angioedema in U.S.
4. Child Neurology Foundation Announces the Launch of Infantilespasmsinfo.org
5. Elbit Imaging Ltd. Announces Sale of Plaza Centers Shares
6. Onyx Pharmaceuticals Announces Investor Teleconference and Webcast
7. Kensey Nash Corporation Announces Its First Quarter Fiscal Year 2010 Earnings Release Date and Teleconference
8. ADVENTRX Pharmaceuticals Announces Closing of Financing
9. Stereotaxis Announces Pricing of $26 Million Common Stock Offering
10. Anpath Group, Inc. Announces Expansion of Its Distributor Network
11. DOTmed Announces Certified Parts Vendor (CPV) Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... , March 29, 2017  The leader in accelerated ... Drs. Sam Daher , Manal Ibrahim , ... David Couchat will be the featured microlecture presenters at ... American Association of Orthodontists (AAO) Annual Session, April 21-25, ... the microlectures beginning daily at 11:20 a.m. On the ...
(Date:3/29/2017)... , March 29, 2017  Glenmark Pharmaceuticals, a ... GSP 301, an investigational fixed-dose combination of mometasone ... administered twice-daily as a nasal spray being studied ... results are from a recently completed Phase 3 ... 301 combination therapy versus mometasone, olopatadine or placebo. ...
(Date:3/29/2017)... 29, 2017 Transparency Market ... provides an exhaustive study of the U.S. substance abuse ... companies are functional in this market at present, ... leading companies, such as GlaxoSmithKline Plc., Pfizer Inc., ... on various marketing strategies to increase their visibility, ...
Breaking Medicine Technology:
(Date:3/29/2017)... ... March 29, 2017 , ... ARI Network Services, Inc. (NASDAQ: ARIS) ... eligible dealer websites for its network of more than 650 U.S.-based dealers. Rhino, a ... equipment including rotary and flail mowers and cutters, rear blades, post hole diggers, pasture ...
(Date:3/29/2017)... NY (PRWEB) , ... March 29, 2017 , ... ... men’s and women’s professional squash, announced it has enlisted New York City-based sports ... The agency will develop and procure sponsorship opportunities for the Professional Squash Association ...
(Date:3/29/2017)... ... ... main cause of hay fever in the United States, with an estimated 95 percent of ... July each year; with the worst time for sufferers being June and July. , ... provide an effective defense against grass pollen; they are proven in independent studies to trap ...
(Date:3/29/2017)... ... March 30, 2017 , ... Youth Futures International (YFI) premiered ... feedback from high school and college students who have participated in the program every ... and YFI is now accepting applications for enrollment. Visit http://www.ghana.yfiexperience.org to ...
(Date:3/29/2017)... ... 30, 2017 , ... Sports Brand EXOUS Bodygear announced today a special sale ... for the remaining days of March, the price will be only $19.97. The EXOUS ... of just $10 (regular retail price $19.97). , The special promotional prices are to ...
Breaking Medicine News(10 mins):